Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AYTU – Aytu BioPharma, Inc.

Aytu BioPharma, Inc.
AYTU
$1.35
Name : Aytu BioPharma, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $8,329,432.00
EPSttm : -2.08
finviz dynamic chart for AYTU
Aytu BioPharma, Inc.
$1.35
3.05%
$0.04

Float Short %

2.27

Margin Of Safety %

19

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

2.86

EPS This/Next Y

Price

1.37

Target Price

8

Analyst Recom

1

Performance Q

-2.88

Relative Volume

17.64

Beta

-0.08

Ticker: AYTU




23 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-14AYTU1N/AN/A0
2025-04-15AYTU1.04N/AN/A0
2025-04-16AYTU1.03N/AN/A0
2025-04-17AYTU1.0101N/AN/A0
2025-04-18AYTU1.0101N/AN/A0
2025-04-21AYTU1N/AN/A0
2025-04-22AYTU1.04N/AN/A0
2025-04-23AYTU1.06N/AN/A0
2025-04-24AYTU1.05N/AN/A0
2025-04-25AYTU1.11N/AN/AN/A
2025-04-28AYTU1.085N/AN/AN/A
2025-04-29AYTU1.07N/AN/A0
2025-04-30AYTU1.335N/AN/A0
2025-05-01AYTU1.36N/AN/A0
2025-05-02AYTU1.28N/AN/A0
2025-05-05AYTU1.3N/AN/A0
2025-05-06AYTU1.25N/AN/A0
2025-05-07AYTU1.21N/AN/A0
2025-05-08AYTU1.22N/AN/A0
2025-05-09AYTU1.22N/AN/A0
2025-05-12AYTU1.24N/AN/A0
2025-05-13AYTU1.27N/AN/A0
2025-05-14AYTU1.38N/AN/A0
DateSymbolLastP/C OIP/C VolTotal OI
23 items Current Page1 of 1




23 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-14AYTU1.00- - 0.00
2025-04-15AYTU1.04- - 0.00
2025-04-16AYTU1.03- - 0.00
2025-04-17AYTU1.01- - 0.00
2025-04-18AYTU1.01- - 0.00
2025-04-21AYTU1.00- - 0.00
2025-04-22AYTU1.05- - 0.00
2025-04-23AYTU1.06- - 0.00
2025-04-24AYTU1.05- - 0.00
2025-04-25AYTU1.11- - 0.00
2025-04-28AYTU1.09- - 0.00
2025-04-29AYTU1.07- - 0.00
2025-04-30AYTU1.27- - 0.00
2025-05-01AYTU1.34- - 0.00
2025-05-02AYTU1.31- - 0.00
2025-05-05AYTU1.31- - 0.00
2025-05-06AYTU1.30- - 0.00
2025-05-07AYTU1.21- - 0.00
2025-05-08AYTU1.22- - 0.00
2025-05-09AYTU1.21- - 0.00
2025-05-12AYTU1.24- - 0.00
2025-05-13AYTU1.29- - 0.00
2025-05-14AYTU1.37- - 0.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
23 items Current Page1 of 1




23 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-14AYTU8.95-29.551.96
2025-04-15AYTU8.95-29.551.96
2025-04-16AYTU8.95-29.551.96
2025-04-17AYTU8.94-29.551.96
2025-04-18AYTU8.95-29.551.96
2025-04-21AYTU8.95-30.231.96
2025-04-22AYTU8.95-30.231.96
2025-04-23AYTU8.94-30.231.96
2025-04-24AYTU8.95-30.231.96
2025-04-25AYTU8.95-30.231.96
2025-04-28AYTU8.95-30.131.98
2025-04-29AYTU8.95-30.131.98
2025-04-30AYTU8.95-30.131.98
2025-05-01AYTU8.95-30.131.98
2025-05-02AYTU8.95-30.131.98
2025-05-05AYTU8.95-26.781.98
2025-05-06AYTU8.95-26.781.98
2025-05-07AYTU8.95-26.781.98
2025-05-08AYTU8.95-26.781.98
2025-05-09AYTU8.94-26.781.98
2025-05-12AYTU8.95-27.092.27
2025-05-13AYTU8.95-27.092.27
2025-05-14AYTU8.95-27.092.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
23 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

8.95

Institutional Transactions

-27.09

Beta

-0.08

Average Sales Estimate Current Quarter

13

Average Sales Estimate Next Quarter

20

Fair Value

1.63

Quality Score

55

Growth Score

44

Sentiment Score

46

Actual DrawDown %

99.6

Max Drawdown 5-Year %

-99.7

Target Price

8

P/E

Forward P/E

0.99

PEG

P/S

0.12

P/B

0.27

P/Free Cash Flow

15.71

EPS

-1.45

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-7.62

Relative Volume

17.64

Return on Equity vs Sector %

-40.7

Return on Equity vs Industry %

-24.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Aytu BioPharma, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 102
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
stock quote shares AYTU – Aytu BioPharma, Inc. Stock Price stock today
news today AYTU – Aytu BioPharma, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AYTU – Aytu BioPharma, Inc. yahoo finance google finance
stock history AYTU – Aytu BioPharma, Inc. invest stock market
stock prices AYTU premarket after hours
ticker AYTU fair value insiders trading